TrialBrain and behavior2021

Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up.

Tom J M van Mierlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.